Microcurrent therapy as the nonpharmacological new protocol against Alzheimer’s disease

Microcurrent therapy as the nonpharmacological new protocol against Alzheimer’s disease

IntroductionAlzheimer’s disease (AD) poses an increasing global health challenge and is marked by gradual cognitive deterioration, memory impairment, and neuroinflammation. Innovative therapeutic approaches as non-pharmacological protocol are urgently needed with side effect risk of drugs. Microcurr...

Full description

Bibliographic Details
Main Authors:	Eun Ho Kim, Won Seok Lee, Jae Hee Lee, Dong Rak Kwon
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Aging Neuroscience
Subjects:	microcurrent therapy Alzheimer’s disease β-Amyloid BACE1 MAPK signaling pathways
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2024.1344072/full

Similar Items

The Potential Neuroprotective Effects of Extracts from Oat Seedlings against Alzheimer’s Disease
by: Won Seok Lee, et al.
Published: (2022-10-01)

Effects of Microcurrent on Oxygen Saturation by Controlling Rectus Abdominis Activity in Preterm Infant With Desaturation During Feeding: A Pilot Study
by: Dong Rak Kwon, et al.
Published: (2021-11-01)

Microcurrent-Mediated Modulation of Myofibroblasts for Cardiac Repair and Regeneration
by: Dipthi Bachamanda Somesh, et al.
Published: (2024-03-01)

Microcurrent stimulation in the treatment of dry and wet macular degeneration
by: Chaikin L, et al.
Published: (2015-12-01)

The Effectiveness of Microcurrent Stimulation Combined with Sound Therapy for Tinnitus Relief: A Preliminary Study
by: Donghyeok Lee, et al.
Published: (2024-01-01)

Evaluation of visual acuity in dry AMD patients after microcurrent electrical stimulation
by: Kevin M. Parkinson, et al.
Published: (2023-06-01)

The role of PrPc in Alzheimer's disease related Amyloid-β hypothesis: a systematic review
by: Tomás Andrade Magalhães Gomes, et al.
Published: (2023-09-01)

Scaffold Morphing and In Silico Design of Potential BACE-1 (β-Secretase) Inhibitors: A Hope for a Newer Dawn in Anti-Alzheimer Therapeutics
by: Shiveena Bhatia, et al.
Published: (2023-08-01)

Role of BACE1 in Alzheimer’s synaptic function
by: Brati Das, et al.
Published: (2017-08-01)

Development and Structural Modification of BACE1 Inhibitors
by: Ting Gu, et al.
Published: (2016-12-01)

New aspects of microcurrent electrical neuromuscular stimulation in sports medicine
by: Hiroto Fujiya, et al.
Published: (2016-03-01)

β-Secretase1 biological markers for Alzheimer’s disease: state-of-art of validation and qualification
by: Harald Hampel, et al.
Published: (2020-10-01)

A novel microcurrent dressing for wound healing in a rat skin defect model
by: Chao Yu, et al.
Published: (2019-07-01)

Glycosaminoglycans from <i>Litopenaeus vannamei</i> Inhibit the Alzheimer’s Disease β Secretase, BACE1
by: Courtney J. Mycroft-West, et al.
Published: (2021-04-01)

The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-11-01)

Microcurrent behavior of core-shell droplet deposition in coaxial electrohydrodynamic printing
by: Chen Huatan, et al.
Published: (2023-01-01)

Fangchinoline alleviates cognitive impairments through enhancing autophagy and mitigating oxidative stress in Alzheimer’s disease models
by: Lilin Yi, et al.
Published: (2023-12-01)

Wireless microcurrent-generating antimicrobial wound dressing in primary total knee arthroplasty: a single-center experience
by: James Chow
Published: (2016-06-01)

The Pursuit of the “Inside” of the Amyloid Hypothesis—Is C99 a Promising Therapeutic Target for Alzheimer’s Disease?
by: Nobumasa Takasugi, et al.
Published: (2023-01-01)

The Perspective of Dysregulated LncRNAs in Alzheimer's Disease: A Systematic Scoping Review
by: Mohammad Reza Asadi, et al.
Published: (2021-09-01)

Cardio‐microcurrent device for chronic heart failure: first‐in‐human clinical study
by: Dragana Kosevic, et al.
Published: (2021-04-01)

BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01)

Developing and testing an Arduino-based microcurrent stimulator to mimic marine electric pollution on benthos
by: Davide Lattanzi, et al.
Published: (2024-01-01)

Triptolide treatment reduces Alzheimer’s disease (AD)-like pathology through inhibition of BACE1 in a transgenic mouse model of AD
by: Qi Wang, et al.
Published: (2014-12-01)

Association between Patients’ Body Mass Index and the Effect of Monophasic Pulsed Microcurrent Stimulation on Pressure Injury Healing
by: Yoshiyuki Yoshikawa, et al.
Published: (2023-08-01)

Observational Study to Assesses the Efficacy and Safety of Microcurrent Therapy with a Portable Device in Patients Suffering from Chronic Back Pain, Skeletal System Pain, Fibromyalgia, Migraine or Depression
by: Marmann P, et al.
Published: (2023-12-01)

Roles of eIF2α kinases in the pathogenesis of Alzheimer’s disease
by: Masuo eOhno, et al.
Published: (2014-04-01)

Electroacupuncture reduces Aβ production and BACE1 expression in SAMP8 mice
by: Weiguo eDong, et al.
Published: (2015-07-01)

Insights from Drosophila melanogaster model of Alzheimer's disease
by: Nguyen Trong Tue, et al.
Published: (2020-01-01)

Use of Peptides for the Management of Alzheimer’s Disease: Diagnosis and Inhibition
by: Mohammad H. Baig, et al.
Published: (2018-02-01)

Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment
by: Judite R. M. Coimbra, et al.
Published: (2018-05-01)

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study
by: Maarten Timmers, et al.
Published: (2018-08-01)

BACE1 Function and Inhibition: Implications of Intervention in the Amyloid Pathway of Alzheimer’s Disease Pathology
by: Gerald Koelsch
Published: (2017-10-01)

Self-Rated Recovery and Mood Before and After Resistance Training and Muscle Microcurrent Application
by: Bernd A. C. Stößlein, et al.
Published: (2022-04-01)

Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models
by: Teemu Natunen, et al.
Published: (2016-01-01)

Discovery of polymethoxyflavones from black ginger (Kaempferia parviflora) as potential β-secretase (BACE1) inhibitors
by: Kumju Youn, et al.
Published: (2016-01-01)

Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease
by: Michael F. Egan, et al.
Published: (2019-08-01)

Pro-inflammatory interleukin-18 increases Alzheimer’s disease-associated amyloid-β production in human neuron-like cells
by: Sutinen Elina M, et al.
Published: (2012-08-01)

Effectiveness of transcutaneous electrical nerve stimulation and microcurrent electrical nerve stimulation in bruxism associated with masticatory muscle pain - A comparative study
by: Rajpurohit Bharat, et al.
Published: (2010-01-01)

Alzheimer’s associated amyloid and tau deposition co-localizes with a homeostatic myelin repair pathway in two mouse models of post-stroke mixed dementia
by: Thuy-Vi V. Nguyen, et al.
Published: (2018-09-01)